Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

Affiliations

¹ University of Michigan Medical School, 3520D MSRB I 1150 W Medical Center Dr, Ann Arbor, MI, 48109, USA.
² Department of Neurosurgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
³ The Ohio State University College of Medicine, Columbus, OH, USA.
⁴ University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
⁵ University of Michigan Medical School, 3520D MSRB I 1150 W Medical Center Dr, Ann Arbor, MI, 48109, USA. ckoschma@med.umich.edu.

Published Erratum

Kyle Wierzbicki et al. Curr Oncol Rep. 2020.

. 2020 Apr 16;22(5):47.

doi: 10.1007/s11912-020-00912-z.

¹ University of Michigan Medical School, 3520D MSRB I 1150 W Medical Center Dr, Ann Arbor, MI, 48109, USA.
² Department of Neurosurgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
³ The Ohio State University College of Medicine, Columbus, OH, USA.
⁴ University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
⁵ University of Michigan Medical School, 3520D MSRB I 1150 W Medical Center Dr, Ann Arbor, MI, 48109, USA. ckoschma@med.umich.edu.

Abstract

The original version of this review article unfortunately contained a mistake in the author group section.

Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Wierzbicki K, Ravi K, Franson A, Bruzek A, Cantor E, Harris M, Homan MJ, Marini BL, Kawakibi AR, Ravindran R, Teodoro R, Yadav VN, Koschmann C. Wierzbicki K, et al. Curr Oncol Rep. 2020 Feb 6;22(2):19. doi: 10.1007/s11912-020-0877-0. Curr Oncol Rep. 2020. PMID: 32030483 Free PMC article. Review.